These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10749314)

  • 1. Tissue plasminogen activator in the treatment of vitreoretinal diseases.
    Kamei M; Estafanous M; Lewis H
    Semin Ophthalmol; 2000 Mar; 15(1):44-50. PubMed ID: 10749314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
    Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
    Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator for postvitrectomy fibrin formation.
    Jaffe GJ; Abrams GW; Williams GA; Han DP
    Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of tissue plasminogen activator in postvitrectomy cases.
    Koutsandrea C; Apostolopoulos M; Theodossiadis P
    Int Ophthalmol; 1993 Apr; 17(2):95-100. PubMed ID: 8407122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F; Boehnke M
    Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P; Wang W
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.
    Wu WC; Chang SM; Chen JY; Chang CW
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):363-71. PubMed ID: 11572467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR; Madonna RJ
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
    Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
    Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal tissue plasminogen activator in submacular haemorrhage.
    Singh P; Singh R; Kishore KS; Vig VK; Singh R; Singh B
    Indian J Ophthalmol; 1999 Dec; 47(4):254-5. PubMed ID: 10892486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage.
    Moriarty AP; McAllister IL; Constable IJ
    Eye (Lond); 1995; 9 ( Pt 5)():582-8. PubMed ID: 8543077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
    Wu TT; Sheu SJ
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):62-7. PubMed ID: 15718829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator for preserving inferior peripheral iridectomy patency in eyes with silicone oil.
    MacCumber MW; McCuen BW; Toth CA; Ferrone PJ; Jaffe GJ
    Ophthalmology; 1996 Feb; 103(2):269-73. PubMed ID: 8594513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy.
    Hesse L; Chofflet J; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):323-7. PubMed ID: 8751095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
    Johnson RN; Olsen KR; Hernandez E
    Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tissue plasminogen activator on premacular hemorrhage.
    Chung J; Kim MH; Chung SM; Chang KY
    Ophthalmic Surg Lasers; 2001; 32(1):7-12. PubMed ID: 11195747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of enzyme in vitreoretinal surgery].
    Czajka M; Pecold K
    Klin Oczna; 2002; 104(1):59-62. PubMed ID: 12046313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
    Min WK; Kim YB; Ahn BH; Seong GH
    Korean J Ophthalmol; 1994 Dec; 8(2):45-8. PubMed ID: 7853730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Posterior Vitreous Detachment in Pediatric Vitrectomy by Preoperative Intravitreal Injection of Tissue Plasminogen Activator.
    Chuang CC; Chen SN
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):113-8. PubMed ID: 27018884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.